$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed lower by over 200 points on Wednesday. When insiders purchase or sell shares,…
$3.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones index closed above the $40,000 mark on Friday. When insiders purchase or sell shares, it…
Standard BioTools Announces Multi-Year Strategic Engagement With Bristol Myers Squibb For Use Of The SomaScan Platform For Translational Medicine Research Through 2026
Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced that it has entered into a multi-year engagement with
Standard BioTools And Navignostics Announce Collaboration Agreement To Advance Imaging Capabilities In Personalized Medicine
Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health™ – today announced a collaboration agreement with Navignostics AG for development of
Standard BioTools Announces Full Year 2023 Revenue Of $106M; SomaLogic Expects Q4 2023 Revenue Of ~$23M And FY23 Revenue Of ~$86M
Standard BioTools Inc. (NASDAQ:LAB) (Standard BioTools or the Company), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced Standard BioTools and SomaLogic, Inc.
SomaLogic Issues Letter To Stockholders Reiterating Recommendation For Value Maximizing Merger With Standard BioTools
Combination Builds Scale and Accelerates Path to Profitability, Unlocking Significant Potential Value for SomaLogic Stockholders Madryn's Concerns are Not Based on Facts, and Madryn Selectively Ignores Risks in a
Skye Fund III Issues Letter Regarding Opposition To SomaLogic’s Proposed Merger With Standard BioTools; Believes That The Proposed Merger Grossly Undervalues SomaLogic
Believes that the Proposed Merger Grossly Undervalues SomaLogic and Ignores its Revolutionary Products, Considerable Cash Position, and Strong Balance Sheet Iterates that SomaLogic can Thrive as a Standalone
Standard BioTools And SomaLogic Announce Date For Special Meetings Of Stockholders To Vote On Proposed Merger
Standard BioTools Inc. (NASDAQ:LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – and SomaLogic, Inc. (NASDAQ:SLGC), a leader in data-driven proteomics technology, today
Earnings Scheduled For November 7, 2023
Companies Reporting Before The Bell
• CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Vivos Therapeutics (NASDAQ:VVOS) shares moved upwards by 105.4% to $0.38 during Wednesday’s regular session. The current volume…